PDEX
Price
$63.95
Change
-$0.45 (-0.70%)
Updated
Jun 23, 04:06 PM (EDT)
Capitalization
204.82M
58 days until earnings call
Intraday BUY SELL Signals
ZBH
Price
$87.64
Change
+$0.55 (+0.63%)
Updated
Jun 23, 04:20 PM (EDT)
Capitalization
16.85B
42 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

PDEX vs ZBH

PDEX vs ZBH Comparison Chart in %
View a ticker or compare two or three
VS
PDEX vs. ZBH commentary
Jun 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PDEX is a Hold and ZBH is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 23, 2026
Stock price -- (PDEX: $64.15 vs. ZBH: $87.09)
Brand notoriety: PDEX and ZBH are both not notable
PDEX represents the Pharmaceuticals: Other, while ZBH is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: PDEX: 270% vs. ZBH: 84%
Market capitalization -- PDEX: $204.82M vs. ZBH: $16.85B
PDEX [@Pharmaceuticals: Other] is valued at $204.82M. ZBH’s [@Medical/Nursing Services] market capitalization is $16.85B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $142.71B to $0. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $152.98B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $7.5B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PDEX’s FA Score shows that 1 FA rating(s) are green whileZBH’s FA Score has 1 green FA rating(s).

  • PDEX’s FA Score: 1 green, 4 red.
  • ZBH’s FA Score: 1 green, 4 red.
According to our system of comparison, PDEX is a better buy in the long-term than ZBH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PDEX’s TA Score shows that 4 TA indicator(s) are bullish while ZBH’s TA Score has 4 bullish TA indicator(s).

  • PDEX’s TA Score: 4 bullish, 4 bearish.
  • ZBH’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, PDEX is a better buy in the short-term than ZBH.

Price Growth

PDEX (@Pharmaceuticals: Other) experienced а +0.67% price change this week, while ZBH (@Medical/Nursing Services) price change was -1.33% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -2.31%. For the same industry, the average monthly price growth was -0.98%, and the average quarterly price growth was -14.76%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -0.22%. For the same industry, the average monthly price growth was -3.84%, and the average quarterly price growth was -16.30%.

Reported Earning Dates

PDEX is expected to report earnings on Aug 20, 2026.

ZBH is expected to report earnings on Aug 04, 2026.

Industries' Descriptions

@Pharmaceuticals: Other (-2.31% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical/Nursing Services (-0.22% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ZBH($16.8B) has a higher market cap than PDEX($205M). ZBH has higher P/E ratio than PDEX: ZBH (22.56) vs PDEX (17.67). PDEX YTD gains are higher at: 66.710 vs. ZBH (-2.884). ZBH has higher annual earnings (EBITDA): 2.31B vs. PDEX (18.2M). ZBH has more cash in the bank: 424M vs. PDEX (11M). PDEX has less debt than ZBH: PDEX (19.3M) vs ZBH (7.47B). ZBH has higher revenues than PDEX: ZBH (8.41B) vs PDEX (74.6M).
PDEXZBHPDEX / ZBH
Capitalization205M16.8B1%
EBITDA18.2M2.31B1%
Gain YTD66.710-2.884-2,313%
P/E Ratio17.6722.5678%
Revenue74.6M8.41B1%
Total Cash11M424M3%
Total Debt19.3M7.47B0%
FUNDAMENTALS RATINGS
PDEX vs ZBH: Fundamental Ratings
PDEX
ZBH
OUTLOOK RATING
1..100
5769
VALUATION
overvalued / fair valued / undervalued
1..100
60
Fair valued
9
Undervalued
PROFIT vs RISK RATING
1..100
63100
SMR RATING
1..100
3383
PRICE GROWTH RATING
1..100
3955
P/E GROWTH RATING
1..100
3640
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ZBH's Valuation (9) in the Medical Specialties industry is somewhat better than the same rating for PDEX (60) in the Medical Or Nursing Services industry. This means that ZBH’s stock grew somewhat faster than PDEX’s over the last 12 months.

PDEX's Profit vs Risk Rating (63) in the Medical Or Nursing Services industry is somewhat better than the same rating for ZBH (100) in the Medical Specialties industry. This means that PDEX’s stock grew somewhat faster than ZBH’s over the last 12 months.

PDEX's SMR Rating (33) in the Medical Or Nursing Services industry is somewhat better than the same rating for ZBH (83) in the Medical Specialties industry. This means that PDEX’s stock grew somewhat faster than ZBH’s over the last 12 months.

PDEX's Price Growth Rating (39) in the Medical Or Nursing Services industry is in the same range as ZBH (55) in the Medical Specialties industry. This means that PDEX’s stock grew similarly to ZBH’s over the last 12 months.

PDEX's P/E Growth Rating (36) in the Medical Or Nursing Services industry is in the same range as ZBH (40) in the Medical Specialties industry. This means that PDEX’s stock grew similarly to ZBH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PDEXZBH
RSI
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
68%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
67%
Momentum
ODDS (%)
Bearish Trend 2 days ago
69%
Bearish Trend 2 days ago
67%
MACD
ODDS (%)
Bearish Trend 2 days ago
81%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
60%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
54%
Advances
ODDS (%)
Bullish Trend 29 days ago
82%
Bullish Trend 19 days ago
64%
Declines
ODDS (%)
Bearish Trend 7 days ago
75%
Bearish Trend 13 days ago
58%
BollingerBands
ODDS (%)
Bullish Trend 14 days ago
86%
Bearish Trend 2 days ago
58%
Aroon
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
54%
View a ticker or compare two or three
Interact to see
Advertisement
PDEX
Daily Signal:
Gain/Loss:
ZBH
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PTHS29.280.28
+0.97%
Pelthos Therapeutics Inc
PHIN81.330.55
+0.68%
PHINIA
INM1.500.01
+0.67%
InMed Pharmaceuticals Inc
RGLD214.65-0.17
-0.08%
Royal Gold
CGNT8.12-0.20
-2.40%
Cognyte Software Ltd

PDEX and

Correlation & Price change

A.I.dvisor tells us that PDEX and TCMD have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PDEX and TCMD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PDEX
1D Price
Change %
PDEX100%
-0.34%
TCMD - PDEX
24%
Poorly correlated
-1.47%
PRE - PDEX
23%
Poorly correlated
-2.59%
WAT - PDEX
23%
Poorly correlated
+0.79%
GKOS - PDEX
23%
Poorly correlated
+0.39%
ZBH - PDEX
22%
Poorly correlated
-1.00%
More

ZBH and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZBH has been loosely correlated with KIDS. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if ZBH jumps, then KIDS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZBH
1D Price
Change %
ZBH100%
-1.00%
KIDS - ZBH
45%
Loosely correlated
-3.66%
ENOV - ZBH
45%
Loosely correlated
-3.05%
CNMD - ZBH
44%
Loosely correlated
-0.12%
SYK - ZBH
44%
Loosely correlated
-1.01%
LIVN - ZBH
44%
Loosely correlated
+0.25%
More